サンバイオの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2017/04/03 | 1,185 | 1,186 | 1,156 | 1,169 | -9 | -0.8% | 127,200 |
| 2017/03/31 | 1,156 | 1,188 | 1,156 | 1,178 | +22 | +1.9% | 121,400 |
| 2017/03/30 | 1,181 | 1,199 | 1,156 | 1,156 | -30 | -2.5% | 197,300 |
| 2017/03/29 | 1,160 | 1,192 | 1,153 | 1,186 | +16 | +1.4% | 252,100 |
| 2017/03/28 | 1,084 | 1,192 | 1,080 | 1,170 | +93 | +8.6% | 496,200 |
| 2017/03/27 | 1,080 | 1,122 | 1,075 | 1,077 | +10 | +0.9% | 244,400 |
| 2017/03/24 | 1,073 | 1,081 | 1,060 | 1,067 | -10 | -0.9% | 103,000 |
| 2017/03/23 | 1,030 | 1,080 | 1,021 | 1,077 | +57 | +5.6% | 150,100 |
| 2017/03/22 | 1,035 | 1,048 | 1,019 | 1,020 | -39 | -3.7% | 127,200 |
| 2017/03/21 | 1,036 | 1,065 | 1,012 | 1,059 | -3 | -0.3% | 244,000 |
| 2017/03/17 | 1,083 | 1,084 | 1,056 | 1,062 | -25 | -2.3% | 172,900 |
| 2017/03/16 | 1,062 | 1,090 | 1,060 | 1,087 | +23 | +2.2% | 138,100 |
| 2017/03/15 | 1,083 | 1,090 | 1,064 | 1,064 | -18 | -1.7% | 152,000 |
| 2017/03/14 | 1,102 | 1,105 | 1,072 | 1,082 | -29 | -2.6% | 316,300 |
| 2017/03/13 | 1,128 | 1,130 | 1,111 | 1,111 | -20 | -1.8% | 116,900 |
| 2017/03/10 | 1,150 | 1,150 | 1,121 | 1,131 | +9 | +0.8% | 142,600 |
| 2017/03/09 | 1,133 | 1,148 | 1,122 | 1,122 | -11 | -1% | 149,500 |
| 2017/03/08 | 1,176 | 1,176 | 1,121 | 1,133 | -53 | -4.5% | 495,100 |
| 2017/03/07 | 1,209 | 1,212 | 1,161 | 1,186 | -23 | -1.9% | 353,500 |
| 2017/03/06 | 1,210 | 1,219 | 1,208 | 1,209 | +1 | +0.1% | 91,400 |
| 2017/03/03 | 1,218 | 1,223 | 1,208 | 1,208 | -10 | -0.8% | 150,900 |
| 2017/03/02 | 1,230 | 1,233 | 1,218 | 1,218 | -1 | -0.1% | 83,400 |
| 2017/03/01 | 1,221 | 1,231 | 1,214 | 1,219 | -2 | -0.2% | 125,200 |
| 2017/02/28 | 1,235 | 1,242 | 1,220 | 1,221 | -14 | -1.1% | 142,200 |
| 2017/02/27 | 1,219 | 1,255 | 1,213 | 1,235 | +10 | +0.8% | 282,800 |
| 2017/02/24 | 1,224 | 1,234 | 1,219 | 1,225 | +2 | +0.2% | 112,900 |
| 2017/02/23 | 1,226 | 1,231 | 1,219 | 1,223 | -3 | -0.2% | 117,400 |
| 2017/02/22 | 1,240 | 1,243 | 1,225 | 1,226 | -11 | -0.9% | 71,000 |
| 2017/02/21 | 1,233 | 1,245 | 1,229 | 1,237 | ±0 | ±0% | 53,600 |
| 2017/02/20 | 1,250 | 1,256 | 1,235 | 1,237 | -15 | -1.2% | 77,100 |
| 2017/02/17 | 1,242 | 1,261 | 1,242 | 1,252 | -2 | -0.2% | 42,900 |
| 2017/02/16 | 1,295 | 1,299 | 1,251 | 1,254 | -38 | -2.9% | 138,400 |
| 2017/02/15 | 1,259 | 1,305 | 1,253 | 1,292 | +39 | +3.1% | 373,500 |
| 2017/02/14 | 1,230 | 1,255 | 1,223 | 1,253 | +23 | +1.9% | 160,800 |
| 2017/02/13 | 1,222 | 1,233 | 1,217 | 1,230 | +6 | +0.5% | 96,700 |
| 2017/02/10 | 1,235 | 1,244 | 1,220 | 1,224 | -11 | -0.9% | 99,300 |
| 2017/02/09 | 1,228 | 1,243 | 1,221 | 1,235 | +4 | +0.3% | 74,800 |
| 2017/02/08 | 1,233 | 1,242 | 1,222 | 1,231 | -8 | -0.6% | 76,400 |
| 2017/02/07 | 1,240 | 1,248 | 1,227 | 1,239 | +7 | +0.6% | 60,200 |
| 2017/02/06 | 1,225 | 1,235 | 1,216 | 1,232 | +16 | +1.3% | 78,000 |
| 2017/02/03 | 1,222 | 1,232 | 1,207 | 1,216 | +15 | +1.2% | 150,200 |
| 2017/02/02 | 1,230 | 1,258 | 1,201 | 1,201 | -22 | -1.8% | 222,500 |
| 2017/02/01 | 1,227 | 1,239 | 1,223 | 1,223 | ±0 | ±0% | 94,800 |
| 2017/01/31 | 1,264 | 1,264 | 1,222 | 1,223 | -43 | -3.4% | 157,700 |
| 2017/01/30 | 1,239 | 1,274 | 1,239 | 1,266 | +39 | +3.2% | 190,300 |
| 2017/01/27 | 1,242 | 1,245 | 1,225 | 1,227 | -10 | -0.8% | 208,100 |
| 2017/01/26 | 1,259 | 1,261 | 1,219 | 1,237 | -17 | -1.4% | 271,200 |
| 2017/01/25 | 1,276 | 1,282 | 1,252 | 1,254 | -26 | -2% | 198,600 |
| 2017/01/24 | 1,284 | 1,288 | 1,280 | 1,280 | -4 | -0.3% | 65,100 |
| 2017/01/23 | 1,284 | 1,295 | 1,280 | 1,284 | ±0 | ±0% | 80,200 |
2051～
2100
件表示中 / 2536件
類似銘柄と比較する
現在ご覧いただいている「サンバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| サンバイオ | 253,000円 | - | - | 0.00% | - | 117.18倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| ペプチド | 152,500円 | +5.0% | +1.5% | 0.00% | 13.05倍 | 3.67倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| 鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.45倍 |
|
ＪＴ傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がＴＯＢ実施 |
| 科研薬 | 388,200円 | -6.4% | -71.8% | 4.89% | 43.23倍 | 0.96倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 東和薬品 | 304,000円 | +7.9% | -3.3% | 2.63% | 8.46倍 | 0.87倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム
